TEJWANT CHANDI: Open Payments
NPI 1578562955 · ELIZABETH CITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 16 payments from 7 companies in 2025. Trend: 2023 $535 · 2024 $304 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $121 |
| Novo Nordisk Inc | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Corcept Therapeutics | 2 | $42 |
| ABBVIE INC. | 1 | $18 |
| Amgen Inc. | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: TRELEGY ELLIPTA, Kerendia, Korlym, Rybelsus, Wegovy, QULIPTA, OTEZLA, ELIQUIS.
Industry payments across NC — which companies pay providers there.
